The disconnect between practice guidelines and clinical practice - Stressed out

JAMA

Volumn 300, Issue 15, 2008, Pages 1817-1819

  Diamond, George A ^a,b   Kaul, Sanjay ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL FEATURE; CLINICAL PRACTICE; EDITORIAL; EXERCISE TEST; GEOGRAPHIC DISTRIBUTION; HEALTH CARE UTILIZATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; CORONARY ARTERY DISEASE; EVIDENCE BASED MEDICINE; NOTE; STANDARD; UNITED STATES; UTILIZATION REVIEW;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY DISEASE; EVIDENCE-BASED MEDICINE; EXERCISE TEST; HUMANS; MYOCARDIAL ISCHEMIA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; UNITED STATES;

EID: 54049099304     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.15.1817     Document Type: Editorial

References (21)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999;340(2):115-126.
2. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006;37(7):1923-1932.
3. Smith SC Jr, Feldman TE, Hirshfeld JW, et al. ACC/AHA/ACAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI) Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention. Circulation. 2006;113(7):e166-e286.
4. Gibbons RJ, Antman EM, Alpert JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina). http://www.acc.org/qualityandscience/ clinical/guidelines/stable/summary_article.pdf. Accessed September 1, 2008.
5. Lin GA, Dudley RA, Lucas FL, Malenka DJ, Vittinghoff E, Redberg RF. Frequency of stress testing to document ischemia prior to elective percutaneous coronary intervention. JAMA. 2008;300(15):1765-1773.
6. Topol EJ, Ellis SG, Cosgrove DM, et al. Analysis of coronary angioplasty practice in the United States with an insurance-claims data base. Circulation. 1993;87(5):1489-1497.
7. Chen G, Redberg RF. Noninvasive diagnostic testing of coronary artery disease in women. Cardiol Rev. 2000;8(6):354-360.
8. Bairey Merz N, Bonow RO, Sopko G, et al. Women's ischemic syndrome evaluation: current status and future research directions: report of the National Heart, Lung, and Blood Institute workshop: October 2-4, 2002: executive summary. Circulation. 2004;109(6):805-807.
9. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283-1291.
10. Mahmarian JJ, Dakik HA, Filipchuk NG, et al. An initial strategy of intensive medical therapy is comparable to that of coronary revascularization for suppression of scintigraphic ischemia in high-risk but stable survivors of acute myocardial infarction. J Am Coll Cardiol. 2006;48(12):2458-2467.
11. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997;95(8):2037-2043.
12. Erne P, Schoenenberger AW, Burckhardt D, et al. Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial. JAMA. 2007;297(18):1985-1991.
13. Boden WE, O'Rourke RA, Tao KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503-1516.
14. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359(7):677-687.
15. Samuels BA, Diamond GA, Mahrer PR, Denton TA. Intensity of antianginal therapy in patients referred for coronary angiography: a comparison of fee-for-service and health maintenance organization therapeutic strategies. Clin Cardiol. 2000;23(3):165-170.
16. Freidson E. Profession of Medicine: A Study of the Sociology of Applied Knowledge. New York, NY: Harper & Row; 1970:168-169.
17. Lin GA, Dudley A, Redberg RF. Cardiologists' use of percutaneous coronary interventions for stable coronary artery disease. Arch Intern Med. 2007;167(15):1604-1609.
18. Diamond GA, Denton TA, Matloff JM. Fee-for-benefit: a strategy to improve the quality of health care and control costs through reimbursement incentives. J Am Coll Cardiol. 1993;22(2):343-352.
19. Brush JE Jr, Krumholz HM, Wright JS, et al. American College of Cardiology 2006 principles to guide physician pay-for-performance programs: a report of the American College of Cardiology Work Group on Pay for Performance (A Joint Working Group of the ACC Quality Strategic Direction Committee and the ACC Advocacy Committee). J Am Coll Cardiol. 2006;48(12):2603-2609.
20. Glickman SW, Ou FS, DeLong ER, et al. Pay for performance, quality of care, and outcomes in acute myocardial infarction. JAMA. 2007;297(21):2373-2380.
21. Kaul S, Shah PK, Diamond GA. As time goes by: current status and future directions in the controversy over stenting. J Am Coll Cardiol. 2007;50:127-137.